ALERT: New Isis Pharmaceuticals SEC Filing

A Form 4 regarding Isis Pharmaceuticals has been filed with the United States Securities and Exchange Commission. To View the filing please click here If you are unable to click on the link above, please copy and paste the URL below into a web browser http://ir.isispharm.com/phoenix.zhtml?c=222170&p=IROL-sec Thomson Reuters Inc. 22 Thomson Place Boston, MA 02210 Click Here to unsubscribe from this JoinMail list.

---